Dr. Alain Milot received his medical degree from Laval University in 1985. Following his residency in internal medicine, he completed a fellowship in clinical pharmacology at the Clinical Research Institute of Montreal. He holds a master’s degree in pharmacology from the Université de Montréal and is a certified specialist in clinical hypertension from the American Society of Hypertension. He is also a fellow of the Society for Vascular Medicine.
He has been practicing at the Hôpital Saint-François d’Assise of the CHU de Québec since 1996 where he heads the group of vascular medicine. In addition, he is an Associate Professor of Medicine at Laval University and Director of the vascular medicine fellowship program.
He is a regular researcher in the Populations Health and Optimal Health Practices Area at the CHU de Québec Research Center. His main clinical and epidemiological research projects focus on the study of the relationships between adverse psychosocial work factors, cardiovascular risk factors, masked hypertension, cardiovascular diseases and cognitive functions.
Dr. Milot is a former president of the Société québécoise d’hypertension artérielle as well as co-editor-in-chief of the Therapeutic Guide published by this society. He is also a member of the committee that provides annually-updated Hypertension Canada Guidelines.
10, rue de l'Espinay
Canada G1L 3L5
- Fréchette, AnnieEmployeeHôpital Saint-François d'Assise+1 418-525-4444, extension firstname.lastname@example.org
10 Rue de l'Espinay
Canada G1L 3L5
- Nadeau, GuylaineEmployeeHôpital Saint-François d'Assise
10, rue de l'Espinay
Canada G1L 3L52400 Avenue D'Estimauville+1 418-525-4444, extension 53281+1 418-666-7000, extension 10224+1 email@example.com@crchudequebec.ulaval.ca
Canada G1E 6W2
- Richard, ElizabethMaster student
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trialJournal Article
Lancet, 394 (10193), 2019.
Assessment of the healthy worker survivor effect in the relationship between psychosocial work-related factors and hypertensionJournal Article
Occup Environ Med, 76 (6), 2019.
Psychosocial Stressors at Work and Ambulatory Blood PressureJournal Article
Curr Cardiol Rep, 20 (12), 2018.
Cohort Profile: The PROspective Québec (PROQ) Study on Work and HealthJournal Article
Int J Epidemiol, 47 (3), 2018.
Hypertension Canada's 2018 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults and ChildrenJournal Article
Can J Cardiol, 34 (5), 2018.
Le MAPA. Au coeur du diagnostic et du suivi de l'hypertension artérielleJournal Article
Perspect Infirm, 14 (3), 2017.
Double Exposure to Adverse Psychosocial Work Factors and High Family Responsibilities as Related to Ambulatory Blood Pressure at Work: A 5-Year Prospective Study in Women With White-Collar JobsJournal Article
Psychosom Med, 79 (5), 2017.
Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery DiseaseJournal Article
N Engl J Med, 376 (1), 2017.
Masked hypertension and effort-reward imbalance at work among 2369 white-collar workersJournal Article
J Hum Hypertens, 31 (10), 2017.
Ticagrelor Compared With Clopidogrel in Patients With Prior Lower Extremity Revascularization for Peripheral Artery DiseaseJournal Article
Circulation, 135 (3), 2017.
- Coûts des maladies cardiovasculaires et des problèmes de santé mentale attribuables aux contraintes psychosociales au travail : Une étude longitudinale de 22 ans auprès de 9 000 cols blancs., from 2016-07-01 to 2024-03-31
- Prévenir l’hypertension, le diabète de type 2 et les maladies cardiovasculaires en ciblant les stresseurs psychosociaux au travail, les longues heures de travail et les mauvaises habitudes de vie : Des fractions, from 2022-10-01 to 2026-03-31